Administrative Core Fragile X

BCM-MRDDRC的组织结构图见上文二.A.2节(图二.A.1)。它 概述主任、协理主任和 研究核心和单个研究项目的行政核心。由于数量较多 在BCM MRDDRC中批准访问核心的研究项目，我们由以下人员代表它们 它们的主题，括号中的数字表明了各个项目的数量 在每个主题中受支持。上文表二.A.2分别列出了这些项目。 经内部咨询委员会推荐，胡达·佐格比博士被任命为主任 在爱德华·麦凯布医生离开BCM到加州大学洛杉矶分校担任儿科主任后。佐格比博士一直是世界卫生组织 BCM在MRDDRC工作了八年多，并将继续担任这一职务。她是经过认证的董事会成员。 具有丰富研究成果的儿科神经科医生。她带来了对许多人类遗传性疾病的兴趣和经验，其中精神发育迟滞是一个组成部分。她对雷特综合症特别感兴趣。佐格比博士是儿科学、神经学、神经科学以及分子和人类遗传学的教授，也是霍华德·休斯医学研究所的研究员。 David Nelson博士在目前的资助期间担任BCM MRDDRC的副主任 在这次拟议的续展中，他将继续发挥这一作用。纳尔逊博士是人类分子 遗传学家，为MRDDRC带来了对精神发育迟滞的广泛经验和兴趣 通过他对脆性X综合征、FRAXE综合征和大小便失禁的研究 色素基因及其产物。他还拥有管理大型中心的经验 美国国立卫生研究院资助的BCM人类基因组中心副主任兼主任。纳尔逊医生将会 如果主任丧失行为能力，负责BCM MRDDRC，他将继续 与行政和行政部门一起，就解除武装、复员和重返社会中心的运作向主任提供咨询和协助 科学咨询委员会。

The organizational chart of the BCM MRDDRC is shown under section II.A.2 above (Figure II.A.1). It outlines the administrative responsibilities of the Director, the Associate Director and the Administrative Core to the Research Cores and individual research projects. Due to the number of research projects approved for access to cores in the BCM MRDDRC, we have represented them by their thematic topics, with a number in parentheses indicating the number of individual projects supported within each theme. Table II.A.2, above, lists the projects individually. Dr. Huda Zoghbi was appointed Director upon recommendation of the internal advisory committee after Dr. Edward McCabe left BCM to chair Pediatrics at UCLA. Dr. Zoghbi has been Director of the BCM MRDDRC for over eight years and will continue in that capacity. She is a board certified pediatric neurologist with abundant research accomplishments. She brings interest in and experience with numerous human genetic disorders with mental retardation as a component. She has a particular interest in Rett syndrome. Dr. Zoghbi is Professor of Pediatrics, Neurology, Neurosciences and Molecular and Human Genetics and an investigator of the Howard Hughes Medical Institute. Dr. David Nelson has served as Associate Director of the BCM MRDDRC during the current funding cycle, and will continue in that role in this proposed renewal. Dr. Nelson is a human molecular geneticist who brings extensive experience and interest in mental retardation to the MRDDRC through his activities in characterizing the fragile X syndrome, FRAXE syndrome and incontinentia pigmenti genes and their products. He also has prior experience in managing large Centers both Associate Director and Director of the NIH-funded BCM Human Genome Center. Dr. Nelson will be responsible for the BCM MRDDRC should the Director become incapacitated and he will continue to advise and assist the Director in the operation of the MRDDRC along with the Administrative and Scientific Advisory Committee.